We serve Chemical Name:2-Hydroxy-N,N-dimethylpropanamide CAS:35123-06-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-Hydroxy-N,N-dimethylpropanamide
CAS.NO:35123-06-9
Synonyms:Propanamide, 2-hydroxy-N,N-dimethyl-;2-Hydroxy-N,N-dimethylpropanamide;N,N-dimethyllactamide
Molecular Formula:C5H11NO2
Molecular Weight:117.146
HS Code:2924199090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:200.2±23.0 °C at 760 mmHg
Density:1.0±0.1 g/cm3
Index of Refraction:1.450
PSA:40.54000
Exact Mass:117.078979
LogP:-1.20
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Propanamide, 2-hydroxy-N,N-dimethyl- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N,N-dimethyllactamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N,N-dimethyllactamide Use and application,Propanamide, 2-hydroxy-N,N-dimethyl- technical grade,usp/ep/jp grade.
Related News: Patients given the vaccine also experienced a reduction in cerebrospinal fluid biomarkers of abnormal tau, results show. 2-Hydroxy-N,N-dimethylpropanamide manufacturer Separately, Europe’s drug regulator said on Friday that batches of J&J COVID-19 vaccine made for the region around the time the contamination issues were revealed at the Baltimore plant would, as a precaution, not be used. 2-Hydroxy-N,N-dimethylpropanamide supplier In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase. 2-Hydroxy-N,N-dimethylpropanamide vendor The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it. 2-Hydroxy-N,N-dimethylpropanamide factory Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.
